DE69820422D1 - Verwendung von beta-3-adrenorezeptoragonisten zur herstellung von wundheilmitteln - Google Patents

Verwendung von beta-3-adrenorezeptoragonisten zur herstellung von wundheilmitteln

Info

Publication number
DE69820422D1
DE69820422D1 DE69820422T DE69820422T DE69820422D1 DE 69820422 D1 DE69820422 D1 DE 69820422D1 DE 69820422 T DE69820422 T DE 69820422T DE 69820422 T DE69820422 T DE 69820422T DE 69820422 D1 DE69820422 D1 DE 69820422D1
Authority
DE
Germany
Prior art keywords
adrenor
beta
manufacture
wound healing
receptor agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69820422T
Other languages
English (en)
Other versions
DE69820422T2 (de
Inventor
Andre Bernat
Jean-Marc Herbert
Michele Arnone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of DE69820422D1 publication Critical patent/DE69820422D1/de
Application granted granted Critical
Publication of DE69820422T2 publication Critical patent/DE69820422T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69820422T 1997-01-21 1998-01-21 Verwendung von beta-3-adrenorezeptoragonisten zur herstellung von wundheilmitteln Expired - Fee Related DE69820422T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9700584 1997-01-21
FR9700584A FR2758460B1 (fr) 1997-01-21 1997-01-21 Utilisation des agonistes des recepteurs beta-3 adrenergiques pour la preparation de medicaments cicatrisants
PCT/FR1998/000105 WO1998031357A1 (fr) 1997-01-21 1998-01-21 Utilisation des agonistes des recepteurs beta-3 adrenergiques pour la preparation de medicaments cicatrisants

Publications (2)

Publication Number Publication Date
DE69820422D1 true DE69820422D1 (de) 2004-01-22
DE69820422T2 DE69820422T2 (de) 2004-10-28

Family

ID=9502810

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69820422T Expired - Fee Related DE69820422T2 (de) 1997-01-21 1998-01-21 Verwendung von beta-3-adrenorezeptoragonisten zur herstellung von wundheilmitteln

Country Status (15)

Country Link
US (1) US6235793B1 (de)
EP (1) EP0966276B1 (de)
JP (1) JP2001508790A (de)
AR (1) AR011546A1 (de)
AT (1) ATE255889T1 (de)
AU (1) AU5994198A (de)
BR (1) BR9807288A (de)
CA (1) CA2278220A1 (de)
DE (1) DE69820422T2 (de)
FR (1) FR2758460B1 (de)
HR (1) HRP980023A2 (de)
NO (1) NO326823B1 (de)
UY (1) UY24848A1 (de)
WO (1) WO1998031357A1 (de)
ZA (1) ZA98484B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2817257B1 (fr) 2000-11-30 2009-03-20 Sanofi Synthelabo Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant
WO2003106423A1 (ja) * 2002-06-12 2003-12-24 住友製薬株式会社 環状アミン類およびそれを含む医薬組成物
BRPI0720558B1 (pt) * 2006-12-22 2018-10-23 National Oilwell Varco Denmark I/S tubo flexível
ATE498087T1 (de) 2006-12-22 2011-02-15 Nkt Flexibles Is Flexibles rohr
US20240148701A1 (en) * 2021-02-22 2024-05-09 The University Of Sydney Would healing methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0029320B1 (de) * 1979-11-15 1985-07-10 Beecham Group Plc Sekundäre Äthanolamine, ihre Herstellung und ihre Verwendung in pharmazeutischen Zusammensetzungen
GB8528633D0 (en) * 1985-11-21 1985-12-24 Beecham Group Plc Compounds
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
US5502078A (en) * 1991-05-28 1996-03-26 Zeneca Limited Chemical compounds
GB9308178D0 (en) * 1993-04-21 1993-06-02 Smithkline Beecham Plc Novel compounds
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
JPH07228543A (ja) * 1994-02-16 1995-08-29 Fujisawa Pharmaceut Co Ltd β3−アドレナリン作動薬の新規医薬用途
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US5512592A (en) * 1994-09-09 1996-04-30 Wake Forest University Method of producing cardiotonic effect and improving cardiac contractile function by administration of carnosine
US5597843A (en) * 1995-06-07 1997-01-28 Houghten Pharmaceuticals Use of a substituted 1,3-benzodioxole to reduce a wasting condition
US5869450A (en) * 1996-03-06 1999-02-09 The Regents Of The University Of California Anti-inflammatory compositions and method with corticotropin-releasing factor analogs

Also Published As

Publication number Publication date
AU5994198A (en) 1998-08-07
FR2758460B1 (fr) 1999-12-31
EP0966276A1 (de) 1999-12-29
US6235793B1 (en) 2001-05-22
NO993548D0 (no) 1999-07-20
FR2758460A1 (fr) 1998-07-24
ATE255889T1 (de) 2003-12-15
HRP980023A2 (en) 1998-10-31
NO993548L (no) 1999-07-20
AR011546A1 (es) 2000-08-30
JP2001508790A (ja) 2001-07-03
EP0966276B1 (de) 2003-12-10
BR9807288A (pt) 2000-03-21
UY24848A1 (es) 1998-04-21
ZA98484B (en) 1998-07-30
CA2278220A1 (en) 1998-07-23
NO326823B1 (no) 2009-02-23
WO1998031357A1 (fr) 1998-07-23
DE69820422T2 (de) 2004-10-28

Similar Documents

Publication Publication Date Title
DE69839241D1 (de) Haltevorrichtung zur Herstellung von Präzisionsteilen
DE69713295T2 (de) Azabicyclishe carbaniumsaureester zur therapeutsichen verwendung
DE69614255D1 (de) Zusammensetzung zur haarpflege
DE69903655D1 (de) Verwendung von menthyl-2-pyrrolidon-5-carboxylat zur insektenabwehr
DE69841198D1 (de) Klebstoffzusammensetzung für chirurgische Zwecke
DE69528011T2 (de) Verfahren zur Pflege der Nägel
DE69940256D1 (de) Zusammensetzung zur hautbleichung
DE69626993D1 (de) Wundbehandlungszusammensetzung
DE69720111D1 (de) Vorläufer von Duftstoffen
DE69838730D1 (de) Zusammensetzung zur zahnbeschichtung
DE69707537T2 (de) Verfahren zur Herstellung von 5-substituierten Tetrazolen
DE69724116D1 (de) Verwendung von hitzebehandelten alumoxanen zur herstellung von trägerkatalysatoren
DE69434777D1 (de) Verwendung von Relaxin zur Herstellung von therapeutischen Mitteln
DE59810715D1 (de) Arzneimittel zur förderung der wundheilung enthaltend thrombozyten
DE69918781D1 (de) Die verwendung von tee-polyphenolen zur herstellung von anti-chlamydia mitteln
DE69728352D1 (de) Beschichtetes Katgut Nahtmaterial
DE69822711D1 (de) Verfarhen zur Herstellung von Dialkylnaphthalinen
DE69510575D1 (de) Verwendung von silikontrennschichtmittel
DE69820422D1 (de) Verwendung von beta-3-adrenorezeptoragonisten zur herstellung von wundheilmitteln
DE59813276D1 (de) Mischung zur Verwendung als Wundverband
DE59811806D1 (de) Verwendung von ausgewählten phytostenolestern zur herstellung von hypocholesterinämischen mitteln
DE69823275D1 (de) Verfahren zur Herstellung von Vorrichtungen zur kontrollierten Freisetzung von Arzneimitteln
DE59812720D1 (de) Verwendung von phytostenol enthaltender wirkstoffmischungen zur herstellung von hypocholesterinämischen mitteln
DE69817782D1 (de) Gel enthaltender wundverband
DE69931316D1 (de) Verwendung von Aryl-Cyclohexylamine Derivaten zur Herstellung von NMDA-Rezeptorblockern

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS, PARIS, FR

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee